Clincosm LogoSign in Get a demo

respiratory syncytial virus infections

Showing 1 - 25 of 132
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Respiratory Syncytial Virus Infections Trial (Placebo, Active)

Not yet recruiting
  • Respiratory Syncytial Virus Infections
  • (no location specified)
Oct 20, 2023

Respiratory Syncytial Virus Infections Trial in China (TNM001, )

Not yet recruiting
  • Respiratory Syncytial Virus Infections
  • TNM001
  • placebo
  • Beijing, Beijing, China
  • +38 more
Oct 11, 2023

Respiratory Syncytial Virus Infections Trial in Japan (Nirsevimab)

Recruiting
  • Respiratory Syncytial Virus Infections
  • Bunkyo-ku, Japan
  • +11 more
Sep 11, 2023

Respiratory Syncytial Virus Infections Trial in London (RV299, Placebo, Midazolam)

Completed
  • Respiratory Syncytial Virus Infections
  • London, Greater London, United Kingdom
    Richmond Pharmacology Ltd
Sep 11, 2023

Respiratory Syncytial Virus Infections Trial in Saint Petersburg (RSV/Flu-01E low dose, RSV/Flu-01E high dose, Placebo)

Active, not recruiting
  • Respiratory Syncytial Virus Infections
  • RSV/Flu-01E low dose
  • +2 more
  • Saint Petersburg, Russian Federation
    Smorodintsev Research Institute of Influenza
Jul 24, 2023

Respiratory Syncytial Virus Disease in Infants and Toddlers

Not yet recruiting
  • Respiratory Syncytial Virus Infections
    • (no location specified)
    Jul 27, 2023

    Respiratory Syncytial Virus Infections Trial in Worldwide (RSVPreF3 OA Investigational Vaccine)

    Not yet recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 OA Investigational Vaccine
    • Phoenix, Arizona
    • +52 more
    Jun 16, 2023

    Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, PCV20)

    Not yet recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 OA investigational vaccine
    • PCV20
    • (no location specified)
    May 18, 2023

    Respiratory Syncytial Virus Infections Trial in Baltimore (200 mg RV521/78 µCi [ 14C]-RV521.)

    Completed
    • Respiratory Syncytial Virus Infections
    • 200 mg RV521/78 µCi [ 14C]-RV521.
    • Baltimore, Maryland
      Pharmaron Clinical Pharmacology Center
    May 15, 2023

    Respiratory Syncytial Virus Infections Trial in Adelaide (Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /,

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /placebo
    • +2 more
    • Herston, Queensland, Australia
    • +1 more
    Feb 1, 2023

    Respiratory Syncytial Virus Infections Trial (RSVPreF3 vaccine, Control)

    Not yet recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 vaccine
    • Control
    • (no location specified)
    Jan 20, 2023

    Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, Placebo)

    Recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 OA investigational vaccine
    • Placebo
    • Daphne, Alabama
    • +56 more
    Jan 20, 2023

    Respiratory Syncytial Virus Infections Trial in United States (MVA-BN-RSV vaccine, Tris Buffered Saline (TBS))

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • MVA-BN-RSV vaccine
    • Tris Buffered Saline (TBS)
    • Athens, Alabama
    • +119 more
    Jan 16, 2023

    Respiratory Syncytial Virus Infections Trial in United States (RSVPreF3 OA investigational vaccine, FLU HD vaccine)

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 OA investigational vaccine
    • FLU HD vaccine
    • Birmingham, Alabama
    • +46 more
    Jan 12, 2023

    Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT, Placebo)

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • RSV MAT
    • Placebo
    • Birmingham, Alabama
    • +162 more
    Dec 22, 2022

    Respiratory Syncytial Virus Infections Trial in Cincinnati (PIV5-vectored RSV Vaccine (BLB-201) Low Dose, PIV5-vectored RSV

    Not yet recruiting
    • Respiratory Syncytial Virus Infections
    • PIV5-vectored RSV Vaccine (BLB-201) Low Dose
    • +2 more
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Dec 20, 2022

    Health and Economic Burden of RSV Amongst Hospitalized Children

    Recruiting
    • Respiratory Syncytial Virus Infections
      • Amman, Jordan
        Jordan University Hospital
      Dec 13, 2022

      Respiratory Syncytial Virus Infections Trial in Changsha (XW001, Placebo)

      Completed
      • Respiratory Syncytial Virus Infections
      • Changsha, Hunan, China
        The Third Hospital of Changsha
      Nov 30, 2022

      Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, FLU vaccine)

      Active, not recruiting
      • Respiratory Syncytial Virus Infections
      • RSVPreF3 OA investigational vaccine
      • FLU vaccine
      • Edegem, Belgium
      • +33 more
      Dec 7, 2022

      Respiratory Syncytial Virus Infections Trial in Cincinnati, North Charleston (CPI-RSV-F Vaccine (BLB-201))

      Completed
      • Respiratory Syncytial Virus Infections
      • CPI-RSV-F Vaccine (BLB-201)
      • Cincinnati, Ohio
      • +1 more
      Dec 5, 2022

      Respiratory Syncytial Virus Infections Trial in Baltimore, Laurel (RSV ?NS2 ?1313 I1314L Vaccine, Placebo)

      Recruiting
      • Respiratory Syncytial Virus Infections
      • RSV ΔNS2 Δ1313 I1314L Vaccine
      • Placebo
      • Baltimore, Maryland
      • +1 more
      Dec 2, 2022

      Respiratory Syncytial Virus Infections Trial in China (TNM001, Placebo)

      Recruiting
      • Respiratory Syncytial Virus Infections
      • TNM001
      • Placebo
      • Shijiazhuang, Hebei, China
      • +5 more
      Nov 18, 2022

      Respiratory Syncytial Virus Infections Trial (CodaVax-RSV, Normal Saline)

      Not yet recruiting
      • Respiratory Syncytial Virus Infections
      • CodaVax-RSV
      • Normal Saline
      • (no location specified)
      Nov 16, 2022

      Respiratory Syncytial Virus Infections Trial in Hakata, Sumida, Kumamoto (VN-0200)

      Recruiting
      • Respiratory Syncytial Virus Infections
      • VN-0200
      • Hakata, Fukuoka, Japan
      • +2 more
      Oct 27, 2022

      RESCEU: Defining the Burden of RSV Disease

      Active, not recruiting
      • Respiratory Syncytial Virus Infections
      • RSV Infection
      • venepuncture
      • nasopharyngeal swab
      • Oxford, Oxfordshire, United Kingdom
        University of Oxford
      Oct 25, 2022